• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

黏液瘤病毒对人胰腺腺癌细胞具有溶瘤作用。

Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells.

作者信息

Woo Yanghee, Kelly Kaitlyn J, Stanford Marianne M, Galanis Charles, Chun Yun Shin, Fong Yuman, McFadden Grant

机构信息

Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.

出版信息

Ann Surg Oncol. 2008 Aug;15(8):2329-35. doi: 10.1245/s10434-008-9924-z. Epub 2008 May 3.

DOI:10.1245/s10434-008-9924-z
PMID:18454298
Abstract

BACKGROUND

Viral oncolytic therapy, which seeks to exploit the use of live viruses to treat cancer, has shown promise in the treatment of cancers resistant to conventional anticancer therapies. Among the most difficult to treat cancers is advanced pancreatic adenocarcinoma. Our study investigates the ability of a novel oncolytic agent, myxoma virus, to infect, productively replicate in, and kill human pancreatic cancer cells in vitro.

METHODS

The myxoma virus vMyxgfp was tested against a panel of human pancreatic adenocarcinoma cell lines. Infectivity, viral proliferation, and tumor cell kill were assessed.

RESULTS

Infection of tumor cells was assessed by expression of the marker gene enhanced green fluorescent protein (e-GFP). vMyxgfp had the ability to infect all pancreatic cancer cell lines tested. Killing of tumor cells varied among the 6 cell lines tested, ranging from >90% cell kill at 7 days for the most sensitive Panc-1 cells, to 39% in the most resistant cell line Capan-2. Sensitivity correlated to replication of virus, and was found to maximally exhibit a four-log increase in foci-forming units for the most sensitive Panc-1 cells within 72 h.

CONCLUSION

Our study demonstrates for the first time the ability of the myxoma virus to productively infect, replicate in, and lyse human pancreatic adenocarcinoma cells in vitro. These data encourage further investigation of this virus, which is pathogenic only in rabbits, for treatment of this nearly uniformly fatal cancer.

摘要

背景

病毒溶瘤疗法旨在利用活病毒治疗癌症,在治疗对传统抗癌疗法耐药的癌症方面已显示出前景。最难治疗的癌症之一是晚期胰腺腺癌。我们的研究调查了一种新型溶瘤剂黏液瘤病毒在体外感染、有效复制并杀死人胰腺癌细胞的能力。

方法

黏液瘤病毒vMyxgfp针对一组人胰腺腺癌细胞系进行了测试。评估了其感染性、病毒增殖和肿瘤细胞杀伤情况。

结果

通过标记基因增强绿色荧光蛋白(e-GFP)的表达评估肿瘤细胞的感染情况。vMyxgfp能够感染所有测试的胰腺癌细胞系。在所测试的6种细胞系中,肿瘤细胞的杀伤情况各不相同,最敏感的Panc-1细胞在7天时细胞杀伤率>90%,而最耐药的细胞系Capan-2为39%。敏感性与病毒复制相关,在最敏感的Panc-1细胞中,在72小时内病灶形成单位最多可呈现四对数级的增加。

结论

我们的研究首次证明了黏液瘤病毒在体外能够有效感染、在人胰腺腺癌细胞中复制并裂解这些细胞。这些数据鼓励对这种仅对兔子致病的病毒进行进一步研究,以治疗这种几乎一致致命的癌症。

相似文献

1
Myxoma virus is oncolytic for human pancreatic adenocarcinoma cells.黏液瘤病毒对人胰腺腺癌细胞具有溶瘤作用。
Ann Surg Oncol. 2008 Aug;15(8):2329-35. doi: 10.1245/s10434-008-9924-z. Epub 2008 May 3.
2
Hyperthermia potentiates oncolytic herpes viral killing of pancreatic cancer through a heat shock protein pathway.高热通过热休克蛋白途径增强溶瘤单纯疱疹病毒对胰腺癌的杀伤作用。
Surgery. 2010 Aug;148(2):325-34. doi: 10.1016/j.surg.2010.05.005.
3
The replication-competent oncolytic herpes simplex mutant virus NV1066 is effective in the treatment of esophageal cancer.具有复制能力的溶瘤单纯疱疹突变病毒NV1066在食管癌治疗中有效。
Surgery. 2003 Aug;134(2):357-64. doi: 10.1067/msy.2003.244.
4
A novel genetically modified oncolytic vaccinia virus in experimental models is effective against a wide range of human cancers.新型基因修饰的溶瘤痘苗病毒在实验模型中对多种人类癌症有效。
Ann Surg Oncol. 2012 Jul;19 Suppl 3:S665-74. doi: 10.1245/s10434-011-2198-x. Epub 2012 Jan 19.
5
Synergistic action of oncolytic herpes simplex virus and radiotherapy in pancreatic cancer cell lines.溶瘤单纯疱疹病毒与放疗联合作用于胰腺癌细胞系。
Br J Surg. 2010 Sep;97(9):1385-94. doi: 10.1002/bjs.7124.
6
Specific oncolytic activity of herpesvirus saimiri in pancreatic cancer cells.赛米利疱疹病毒在胰腺癌细胞中的特异性溶瘤活性。
Br J Cancer. 2000 Aug;83(3):329-32. doi: 10.1054/bjoc.2000.1346.
7
Oncolytic virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus tropism for human tumor cells.溶瘤病毒疗法与信号抑制剂的协同作用:雷帕霉素增强黏液瘤病毒对人肿瘤细胞的嗜性。
J Virol. 2007 Feb;81(3):1251-60. doi: 10.1128/JVI.01408-06. Epub 2006 Nov 15.
8
Efficacy of systemically administered oncolytic vaccinia virotherapy for malignant gliomas is enhanced by combination therapy with rapamycin or cyclophosphamide.雷帕霉素或环磷酰胺联合治疗可增强全身给药的溶瘤痘苗病毒疗法对恶性胶质瘤的疗效。
Clin Cancer Res. 2009 Apr 15;15(8):2777-88. doi: 10.1158/1078-0432.CCR-08-2342. Epub 2009 Apr 7.
9
Treatment of anaplastic thyroid carcinoma in vitro with a mutant vaccinia virus.用突变痘苗病毒体外治疗间变性甲状腺癌。
Surgery. 2007 Dec;142(6):976-83; discussion 976-83. doi: 10.1016/j.surg.2007.09.017. Epub 2007 Nov 5.
10
A novel HSV-1 virus, JS1/34.5-/47-, purges contaminating breast cancer cells from bone marrow.一种新型单纯疱疹病毒1型(HSV-1),JS1/34.5-/47-,可清除骨髓中受污染的乳腺癌细胞。
Clin Cancer Res. 2006 Nov 15;12(22):6853-62. doi: 10.1158/1078-0432.CCR-06-1228.

引用本文的文献

1
Oncolytic viral therapy as a novel potential solution for treatment of pancreatic cancer.溶瘤病毒疗法作为治疗胰腺癌的一种新型潜在解决方案。
Gastroenterol Hepatol Bed Bench. 2025;18(1):53-69. doi: 10.22037/ghfbb.v18i1.3066.
2
Oncolytic Increases Autophagy in Multiple Myeloma.溶瘤病毒增加多发性骨髓瘤中的自噬。
Turk J Haematol. 2024 Mar 1;41(1):16-25. doi: 10.4274/tjh.galenos.2024.2023.0403. Epub 2024 Jan 23.
3
Myxoma Virus Combination Therapy Enhances Lenalidomide and Bortezomib Treatments for Multiple Myeloma.黏液瘤病毒联合疗法增强来那度胺和硼替佐米对多发性骨髓瘤的治疗效果。
Pathogens. 2024 Jan 12;13(1):72. doi: 10.3390/pathogens13010072.
4
Oncolytic virus therapy in cancer: A current review.癌症中的溶瘤病毒疗法:当前综述
World J Virol. 2021 Sep 25;10(5):229-255. doi: 10.5501/wjv.v10.i5.229.
5
Microorganisms in chemotherapy for pancreatic cancer: An overview of current research and future directions.胰腺癌化疗中的微生物:当前研究和未来方向概述。
Int J Biol Sci. 2021 Jun 26;17(10):2666-2682. doi: 10.7150/ijbs.59117. eCollection 2021.
6
Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.扩大对基于水疱性口炎病毒的溶瘤病毒疗法有反应的胰腺癌谱:挑战与解决方案
Cancers (Basel). 2021 Mar 9;13(5):1171. doi: 10.3390/cancers13051171.
7
Treatment of an Alveolar Rhabdomyosarcoma Allograft with Recombinant Myxoma Virus and Oclacitinib.用重组黏液瘤病毒和奥克拉替尼治疗肺泡横纹肌肉瘤同种异体移植物
Oncolytic Virother. 2020 May 26;9:17-29. doi: 10.2147/OV.S252727. eCollection 2020.
8
Recombinant Myxoma Virus Expressing Walleye Dermal Sarcoma Virus orfC Is Attenuated in Rabbits.表达美洲红点鲑疱疹病毒 orfC 的重组兔粘液瘤病毒在兔子中减毒。
Viruses. 2020 May 8;12(5):517. doi: 10.3390/v12050517.
9
Oncolytic virotherapy in hepato-bilio-pancreatic cancer: The key to breaking the log jam?肝胰胆癌的溶瘤病毒疗法:打破僵局的关键?
Cancer Med. 2020 May;9(9):2943-2959. doi: 10.1002/cam4.2949. Epub 2020 Mar 4.
10
Oncolytic Viruses for Canine Cancer Treatment.用于犬类癌症治疗的溶瘤病毒
Cancers (Basel). 2018 Oct 27;10(11):404. doi: 10.3390/cancers10110404.